Fentanyl injection - Daiichi Sankyo Company

Drug Profile

Fentanyl injection - Daiichi Sankyo Company

Alternative Names: CS-1401E; Fentanyl citrate injection - Daiichi Sankyo

Latest Information Update: 12 Mar 2015

Price : $50

At a glance

  • Originator Janssen L.P.
  • Developer Daiichi Sankyo Company
  • Class General anaesthetics; Opioid analgesics; Piperidines; Small molecules
  • Mechanism of Action Opioid mu receptor agonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

  • New Molecular Entity No

Highest Development Phases

  • Marketed Anaesthesia; Pain; Sedation

Most Recent Events

  • 15 Mar 2016 Biomarkers information updated
  • 28 Aug 2007 Registered for Anaesthesia in Japan (Parenteral)
  • 28 Aug 2007 Registered for Pain in Japan (Parenteral)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top